October 1, 2011 (Vol. 31, No. 17)

A Total Solution Provider for the Biopharmaceutical Industry

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry. Our extensive range of technologies, products, and services helps customers to develop and produce drugs safely, timely, and economically.

We are global leaders in bioprocess filtration, fermentation, fluid management technology, and membrane chromatography and in a variety of other purification technologies. Our portfolio features products and integrated solutions for nearly all upstream and downstream steps in the production of active pharmaceutical ingredients.

Single-use products are a particular specialty of our company. We steadily focus on offering our biopharmaceutical customers single-use products to serve their needs in production processes. Single-use products are an innovative alternative to conventional reusable stainless steel systems for our customers thanks to the significant cost savings and time savings they provide. We have the most comprehensive single-use technologies portfolio in the sector. Furthermore, we differentiate ourselves by offering extensive technical consulting and services, which we tailor specifically to the requirements of individual applications.

In addition to conventional laboratory instruments, such as water purification systems, shakers, centrifuges, bioreactors, and fermentors, we offer a range primarily consisting of consumables for the laboratory, including filters, bags, and cell culture vessels.

The respective products of this range help our customers perform small-scale development and testing of active pharmaceutical ingredients first before fully scaling up to large volume production. All of our technologies are fully scalable, so customers can easily increase the quantities of different substances as required for the process phase concerned.

Carefully targeted cooperative arrangements and acquisitions play a central role alongside our own research and development activities in putting this growth strategy into practice. Our R&D department quickly combines the technologies contributed by our partners with our own components to create innovative new products.

Sartorius Stedim Biotech’s strong dedicated sales, distribution, and service organizations and manufacturing companies give it a global presence with a particularly high profile in the major pharmaceutical markets. All of the products and services offered to our customers, most of which are themselves international companies, from our various production facilities around the world meet the same global quality standards.

Strongly rooted in the scientific community and closely allied with customers and technology partners, Sartorius Stedim Biotech is dedicated to its philosophy of “turning science into solutions.”

Headquartered in Aubagne, France, Sartorius Stedim Biotech is listed on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America, and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany. The company employs nearly 2,600 people, and in 2010 earned sales revenue of €432.9 million.

Sartorius Stedim Biotech

ZI Les Paluds

Avenue de Jouques – BP 1051

13781 Aubagne Cedex


Phone +33 442 845600

Website www.sartorius-stedim.com

Date Founded 2007 (merger of the Sartorius Biotechnology Division and Stedim)

Number of Employees 2,600

Previous articleAdvertorial: ATR
Next articleEmergent Wins Potentially $1.25M Anthrax Vaccine Supply Contract